Chargement en cours...
Dexmedetomidine for the management of awake fibreoptic intubation
BACKGROUND: Awake fibreoptic intubation (AFOI) frequently requires sedation, anxiolysis and relief of discomfort without impairing ventilation and depressing cardiovascular function. The goal is to allow the patient to be responsive and co‐operative. Medications such as fentanyl, remifentanil, midaz...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2014
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095023/ https://ncbi.nlm.nih.gov/pubmed/24442817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009798.pub2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|